Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Erin E. Talbert

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4587-0950; OpenAlex author ID A5018838774; NIH RePORTER profile ID 11842360. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 3)
Trials
0
Grants
3
Labs led
1
Collaborators
25
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper, 1 grant · 2020: none · 2021: 1 grant · 2022: 1 paper, 1 grant · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Sex-specific survival but not tissue wasting in the KPP mouse model of pancreatic cancer-induced cachexia. Last author DOI 10.1152/japplphysiol.00706.2025↗
  2. Optimization of a mouse model of pancreatic cancer to simulate the human phenotypes of metastasis and cachexia. Co-author DOI 10.1186/s12885-024-12104-0↗
  3. Retrospective study of testosterone deficiency and symptom burden in patients with pancreatic cancer. Last author DOI 10.21037/tau-22-684↗
  4. Identification of circulating plasma ceramides as a potential sexually dimorphic biomarker of pancreatic cancer-induced cachexia. Last author DOI 10.1002/rco2.68↗
  5. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. First author DOI 10.1016/j.pan.2018.11.002↗
  6. Circulating monocyte chemoattractant protein-1 (MCP-1) is associated with cachexia in treatment-naïve pancreatic cancer patients. Co-author DOI 10.1002/jcsm.12251↗
  7. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions. Co-author DOI 10.1097/mpa.0000000000000898↗

Grants 3

  1. The Extracellular Matrix in Muscle Atrophy R00AR071508↗
  2. Sex-dependent rescue of cancer cachexia R21CA257972↗
  3. The Extracellular Matrix in Muscle Atrophy K99AR071508↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Denis C. Guttridge D · 5 shared papers, 2017–2024 · strength 0.57
  2. Natalia M. Weinzierl · 1 shared paper, 2025 · strength 0.37
  3. Mary E. Dillhoff · 4 shared papers, 2017–2022 · strength 0.36
  4. Jeffery M. Chakedis · 2 shared papers, 2018–2022 · strength 0.23
  5. Martin John Romeo · 1 shared paper, 2024 · strength 0.21
  6. Victoria K. Spadafora · 1 shared paper, 2024 · strength 0.21
  7. Michael C. Ostrowski · 1 shared paper, 2024 · strength 0.21
  8. Timothy Michael Pawlik · 3 shared papers, 2017–2019 · strength 0.20
  9. Phil A. Hart · 3 shared papers, 2017–2019 · strength 0.20
  10. Austin G. Kazarian · 1 shared paper, 2023 · strength 0.18
  11. Carlos H.F. Chan · 1 shared paper, 2023 · strength 0.18
  12. Terence Marques Williams · 1 shared paper, 2022 · strength 0.16
  13. Matthew R. Farren · 2 shared papers, 2018–2019 · strength 0.14
  14. Mitchell L. Ramsey · 2 shared papers, 2018–2019 · strength 0.14
  15. Gregory B. Lesinski · 2 shared papers, 2018–2019 · strength 0.14
  16. Darwin Lewis Conwell · 2 shared papers, 2017–2019 · strength 0.13
  17. Zobeida Cruz‐Monserrate · 2 shared papers, 2017–2019 · strength 0.13
  18. Somashekar Gopala Krishna · 2 shared papers, 2017–2019 · strength 0.13
  19. Tanios Bekaii‐Saab · 2 shared papers, 2017–2019 · strength 0.13
  20. Daniel H. Ahn · 1 shared paper, 2019 · strength 0.07
  21. Mark Bloomston · 1 shared paper, 2019 · strength 0.07
  22. Thomas A. Mace · 1 shared paper, 2019 · strength 0.07
  23. Anne M. Noonan · 1 shared paper, 2019 · strength 0.07
  24. Teresa A Zimmers · 1 shared paper, 2018 · strength 0.07
  25. Laura Nemer · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.